🇺🇸 DASIGLUCAGON HYDROCHLORIDE in United States

FDA authorised DASIGLUCAGON HYDROCHLORIDE on 22 March 2021

Marketing authorisations

FDA — authorised 22 March 2021

  • Application: NDA214231
  • Marketing authorisation holder: ZEALAND PHARMA
  • Local brand name: ZEGALOGUE (AUTOINJECTOR)
  • Indication: SOLUTION — SUBCUTANEOUS
  • Status: approved

Read official source →

FDA

  • Status: approved

DASIGLUCAGON HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DASIGLUCAGON HYDROCHLORIDE approved in United States?

Yes. FDA authorised it on 22 March 2021; FDA has authorised it.

Who is the marketing authorisation holder for DASIGLUCAGON HYDROCHLORIDE in United States?

ZEALAND PHARMA holds the US marketing authorisation.